**Core Concept:** Extraintestinal manifestations (EPIM) of Inflammatory Bowel Disease (IBD) include various systemic complications that occur due to the chronic inflammation, involving not only the gastrointestinal tract but also other organs and systems. The correlation between EPIM and bowel disease activity highlights the systemic nature of IBD and the need for comprehensive assessment and management.

**Why the Correct Answer is Right:** The correct answer, **D** (arthritis), represents a common EPIM associated with IBD, particularly in Crohn's disease. The inflammatory process in IBD can affect the joints, leading to arthritis-like symptoms and joint damage. Inflammatory cytokines and immune cells involved in bowel inflammation can cross the intestinal barrier and reach the joints, causing inflammation and damage. EPIM, such as arthritis, can be used as a surrogate marker of bowel disease activity, as their severity and occurrence correlate with the extent of bowel inflammation.

**Why Each Wrong Option is Incorrect:**

A. **Neuropsychiatric manifestations (NPM):** While IBD patients may experience neuropsychiatric symptoms, they are not directly related to bowel disease activity. Neuropsychiatric manifestations are not a reliable indicator of bowel inflammation and may be influenced by psychological factors, medications, or other medical conditions.

B. **Skin lesions:** Dermatitis herpetiformis (DH) is a dermatological manifestation of celiac disease, not IBD. DH is a gluten-related disorder, and its association with bowel disease activity in IBD is negligible.

C. **Hepatobiliary complications:** Hepatobiliary manifestations (HBM) like cholangitis, cholecystitis, or liver cirrhosis are not directly linked to bowel disease activity. Hepatobiliary complications are usually seen in advanced cases of IBD and are not specific to measure inflammation in the gastrointestinal tract.

**Clinical Pearl:** In clinical practice, it is essential to differentiate EPIM specific to IBD (arthritis) from those unrelated to IBD (NPM, skin lesions, hepatobiliary complications). Assessing EPIM can help evaluate disease activity and guide therapeutic decisions; however, relying solely on EPIM might lead to misinterpretation of disease severity and inappropriate treatment strategies. A comprehensive evaluation of patients with IBD should include both intestinal and extraintestinal manifestations, considering the severity and correlation with bowel disease activity.